These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 24939046)
1. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model. Vannini E; Panighini A; Cerri C; Fabbri A; Lisi S; Pracucci E; Benedetto N; Vannozzi R; Fiorentini C; Caleo M; Costa M BMC Cancer; 2014 Jun; 14():449. PubMed ID: 24939046 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function. Vannini E; Olimpico F; Middei S; Ammassari-Teule M; de Graaf EL; McDonnell L; Schmidt G; Fabbri A; Fiorentini C; Baroncelli L; Costa M; Caleo M Neuro Oncol; 2016 Dec; 18(12):1634-1643. PubMed ID: 27298309 [TBL] [Abstract][Full Text] [Related]
3. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo. Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135 [TBL] [Abstract][Full Text] [Related]
4. Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages. Vannini E; Maltese F; Olimpico F; Fabbri A; Costa M; Caleo M; Baroncelli L Oncotarget; 2017 Apr; 8(14):23539-23550. PubMed ID: 28212563 [TBL] [Abstract][Full Text] [Related]
5. Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1). Tantillo E; Colistra A; Vannini E; Cerri C; Pancrazi L; Baroncelli L; Costa M; Caleo M Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857515 [TBL] [Abstract][Full Text] [Related]
6. Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma. Colarusso A; Maroccia Z; Parrilli E; Germinario EAP; Fortuna A; Loizzo S; Ricceri L; Tutino ML; Fiorentini C; Fabbri A Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32375387 [TBL] [Abstract][Full Text] [Related]
7. Reversible senescence of human colon cancer cells after blockage of mitosis/cytokinesis caused by the CNF1 cyclomodulin from Escherichia coli. Zhang Z; Aung KM; Uhlin BE; Wai SN Sci Rep; 2018 Dec; 8(1):17780. PubMed ID: 30542142 [TBL] [Abstract][Full Text] [Related]
9. Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1. Huelsenbeck SC; Roggenkamp D; May M; Huelsenbeck J; Brakebusch C; Rottner K; Ladwein M; Just I; Fritz G; Schmidt G; Genth H Int J Biochem Cell Biol; 2013 Aug; 45(8):1767-75. PubMed ID: 23732113 [TBL] [Abstract][Full Text] [Related]
10. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model. Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924 [TBL] [Abstract][Full Text] [Related]
11. Long-lasting efficacy of the cognitive enhancer cytotoxic necrotizing factor 1. Borrelli S; Musilli M; Martino A; Diana G Neuropharmacology; 2013 Jan; 64():74-80. PubMed ID: 22659407 [TBL] [Abstract][Full Text] [Related]
12. Effects of the Carlini F; Maroccia Z; Fiorentini C; Travaglione S; Fabbri A Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830494 [TBL] [Abstract][Full Text] [Related]
13. The E. coli CNF1 as a pioneering therapy for the central nervous system diseases. Travaglione S; Loizzo S; Ballan G; Fiorentini C; Fabbri A Toxins (Basel); 2014 Jan; 6(1):270-82. PubMed ID: 24402235 [TBL] [Abstract][Full Text] [Related]
14. Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex. Cerri C; Fabbri A; Vannini E; Spolidoro M; Costa M; Maffei L; Fiorentini C; Caleo M J Neurosci; 2011 Oct; 31(42):15163-72. PubMed ID: 22016550 [TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas. Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109 [TBL] [Abstract][Full Text] [Related]
16. The bacterial protein CNF1 as a new strategy against Plasmodium falciparum cytoadherence. Messina V; Loizzo S; Travaglione S; Bertuccini L; Condello M; Superti F; Guidotti M; Alano P; Silvestrini F; Fiorentini C PLoS One; 2019; 14(3):e0213529. PubMed ID: 30845261 [TBL] [Abstract][Full Text] [Related]
17. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. Munro P; Flatau G; Doye A; Boyer L; Oregioni O; Mege JL; Landraud L; Lemichez E J Biol Chem; 2004 Aug; 279(34):35849-57. PubMed ID: 15152002 [TBL] [Abstract][Full Text] [Related]
18. The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy. Travaglione S; Loizzo S; Vona R; Ballan G; Rivabene R; Giordani D; Guidotti M; Dupuis ML; Maroccia Z; Baiula M; Rimondini R; Campana G; Fiorentini C Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403292 [TBL] [Abstract][Full Text] [Related]
19. The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells. Gall-Mas L; Fabbri A; Namini MRJ; Givskov M; Fiorentini C; Krejsgaard T Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738516 [TBL] [Abstract][Full Text] [Related]